How many pts could become eligible for thrombolysis if the recent DOAC use caution is removed? Our analysis shows about 1 in 20. Check out poster from @kentmokmd at #ISC25. This is an urgent area for further study @DavidSeiffge@ESOstroke@AANmember@CaitPalmisanoNP
Reported incidence of Creutzfeldt-Jakob Disease (CJD) has risen considerably in recent years, disproportionately affecting older and female individuals. Study findings may reflect improved detection of CJD with new diagnostic tools. https://t.co/09tOR5K4Wa
TREND study reports lower rate of neurological deterioration with tirofiban given for 72 hrs compared to aspirin. No clear difference in 90 day outcomes. Larger studies will be of interest @AHAScience #ISC24